USD 14.78
(1.79%)
Year | EBITDA | EBITDA Growth |
---|---|---|
2023 | 75.21 Million USD | 23.82% |
2022 | 62.94 Million USD | 35.43% |
2021 | 77.87 Million USD | -56.56% |
2020 | 144.82 Million USD | 48.92% |
2019 | 102.49 Million USD | -29.73% |
2018 | 112.27 Million USD | -16.76% |
2017 | 141.85 Million USD | 4.95% |
2016 | 125.24 Million USD | 30.31% |
2015 | 96.71 Million USD | 210.49% |
2014 | 74.74 Million USD | -51.85% |
2013 | 68.99 Million USD | -8.28% |
2012 | 72.46 Million USD | 15.48% |
2011 | 61.08 Million USD | 14.15% |
2010 | 56.58 Million USD | 21.92% |
2009 | 47.94 Million USD | -1.21% |
2008 | 44.77 Million USD | -5.76% |
2007 | 43.05 Million USD | 29.61% |
2006 | 33.21 Million USD | 26.43% |
2005 | 26.27 Million USD | 8.58% |
2004 | 24.19 Million USD | 34.6% |
2003 | 17.97 Million USD | 15.79% |
2002 | 15.52 Million USD | 23.92% |
2001 | 12.52 Million USD | 20.94% |
2000 | 10.36 Million USD | 26.34% |
1999 | 10 Million USD | -40.58% |
1998 | 15.2 Million USD | 38.0% |
1997 | 11.4 Million USD | -12.28% |
1996 | 12.5 Million USD | -20.28% |
1995 | 12.1 Million USD | 13.49% |
1994 | 13 Million USD | 12.5% |
1993 | 11.5 Million USD | 43.59% |
1992 | 9.1 Million USD | 95.0% |
1991 | 1.9 Million USD | -79.12% |
1990 | 9.1 Million USD | 26.39% |
1989 | 7.2 Million USD | 100.0% |
Year | EBITDA | EBITDA Growth |
---|---|---|
2024 Q3 | 24.12 Million USD | 607.8% |
2024 Q1 | 21.84 Million USD | -27.22% |
2024 Q2 | 1.28 Million USD | -87.3% |
2023 Q3 | -5.21 Million USD | -153.34% |
2023 FY | - USD | 23.82% |
2023 Q4 | 49.6 Million USD | 1051.47% |
2023 Q1 | 16.2 Million USD | 5.82% |
2023 Q2 | 9.77 Million USD | -39.69% |
2022 Q3 | 2.58 Million USD | -89.28% |
2022 Q2 | 24.16 Million USD | 21.75% |
2022 Q1 | 19.84 Million USD | 617.74% |
2022 FY | - USD | 35.43% |
2022 Q4 | 15.31 Million USD | 491.5% |
2021 Q4 | -3.83 Million USD | -132.33% |
2021 Q1 | 29.33 Million USD | 26.6% |
2021 FY | - USD | -56.56% |
2021 Q2 | 8.35 Million USD | -71.52% |
2021 Q3 | 11.85 Million USD | 41.89% |
2020 Q3 | 29.2 Million USD | 86.21% |
2020 Q1 | 37.17 Million USD | 77.54% |
2020 FY | - USD | 48.92% |
2020 Q4 | 23.17 Million USD | -20.64% |
2020 Q2 | 15.68 Million USD | -57.81% |
2019 Q1 | 3.59 Million USD | -91.69% |
2019 FY | - USD | -29.73% |
2019 Q4 | 20.93 Million USD | -11.77% |
2019 Q3 | 23.73 Million USD | 5.95% |
2019 Q2 | 22.39 Million USD | 522.48% |
2018 Q4 | 43.3 Million USD | 49.71% |
2018 Q2 | 30.67 Million USD | 1407.03% |
2018 Q1 | -2.34 Million USD | -107.43% |
2018 FY | - USD | -16.76% |
2018 Q3 | 28.92 Million USD | -5.7% |
2017 Q3 | 30.05 Million USD | 0.01% |
2017 Q4 | 31.57 Million USD | 5.06% |
2017 Q2 | 30.04 Million USD | 3.11% |
2017 FY | - USD | 4.95% |
2017 Q1 | 29.14 Million USD | -4.01% |
2016 FY | - USD | 30.31% |
2016 Q3 | 27.85 Million USD | 0.63% |
2016 Q4 | 30.35 Million USD | 8.99% |
2016 Q1 | 29.23 Million USD | 220.57% |
2016 Q2 | 27.67 Million USD | -5.31% |
2015 Q2 | 25.77 Million USD | 7.21% |
2015 Q3 | 29.4 Million USD | 14.11% |
2015 Q4 | 9.11 Million USD | -69.0% |
2015 FY | - USD | 210.49% |
2015 Q1 | 24.04 Million USD | 16.52% |
2014 Q3 | -34.98 Million USD | -271.17% |
2014 Q2 | 20.43 Million USD | -8.63% |
2014 Q1 | 22.36 Million USD | 465.82% |
2014 Q4 | 20.63 Million USD | 158.97% |
2014 FY | - USD | -51.85% |
2013 Q2 | 19.42 Million USD | 14.99% |
2013 Q1 | 16.88 Million USD | -10.28% |
2013 Q3 | 18.82 Million USD | -3.06% |
2013 Q4 | 3.95 Million USD | -79.0% |
2013 FY | - USD | -8.28% |
2012 FY | - USD | 15.48% |
2012 Q3 | 16.64 Million USD | -9.87% |
2012 Q2 | 18.47 Million USD | 76.34% |
2012 Q1 | 10.47 Million USD | -29.26% |
2012 Q4 | 18.82 Million USD | 13.07% |
2011 FY | - USD | 14.15% |
2011 Q4 | 14.8 Million USD | -17.26% |
2011 Q2 | 14.25 Million USD | 30.64% |
2011 Q1 | 10.91 Million USD | -18.15% |
2011 Q3 | 17.89 Million USD | 25.57% |
2010 Q2 | 14.94 Million USD | 31.96% |
2010 Q1 | 11.32 Million USD | 14.1% |
2010 Q4 | 13.33 Million USD | 20.52% |
2010 FY | - USD | 21.92% |
2010 Q3 | 11.06 Million USD | -26.01% |
2009 Q3 | 9.95 Million USD | -4.2% |
2009 Q2 | 10.39 Million USD | -8.8% |
2009 FY | - USD | -1.21% |
2009 Q1 | 11.39 Million USD | 0.41% |
2009 Q4 | 9.92 Million USD | -0.29% |
2008 Q4 | 11.35 Million USD | 14.07% |
2008 Q2 | 10.88 Million USD | -3.28% |
2008 FY | - USD | -5.76% |
2008 Q1 | 11.25 Million USD | -1.83% |
2008 Q3 | 9.95 Million USD | -8.56% |
2007 Q1 | 10.33 Million USD | 7.82% |
2007 Q2 | 10.93 Million USD | 5.74% |
2007 FY | - USD | 29.61% |
2007 Q4 | 11.46 Million USD | 10.99% |
2007 Q3 | 10.32 Million USD | -5.54% |
2006 Q2 | 8.38 Million USD | 20.21% |
2006 Q1 | 6.97 Million USD | -3.07% |
2006 FY | - USD | 26.43% |
2006 Q4 | 9.58 Million USD | 15.81% |
2006 Q3 | 8.27 Million USD | -1.21% |
2005 FY | - USD | 8.58% |
2005 Q4 | 7.19 Million USD | 14.6% |
2005 Q3 | 6.27 Million USD | -11.0% |
2005 Q2 | 7.05 Million USD | -80.93% |
2005 Q1 | 36.97 Million USD | 465.0% |
2004 Q1 | 5.69 Million USD | 32.5% |
2004 Q2 | 5.88 Million USD | 3.3% |
2004 Q3 | 6.13 Million USD | 4.27% |
2004 Q4 | 6.54 Million USD | 6.72% |
2004 FY | - USD | 34.6% |
2003 Q2 | 4.61 Million USD | 1.47% |
2003 FY | - USD | 15.79% |
2003 Q4 | 4.29 Million USD | -5.12% |
2003 Q3 | 4.52 Million USD | -1.78% |
2003 Q1 | 4.54 Million USD | 17.92% |
2002 Q3 | 3.98 Million USD | -0.18% |
2002 Q2 | 3.98 Million USD | 7.62% |
2002 Q4 | 3.85 Million USD | -3.2% |
2002 Q1 | 3.7 Million USD | 14.76% |
2002 FY | - USD | 23.92% |
2001 Q2 | 3.11 Million USD | 5.49% |
2001 Q3 | 3.23 Million USD | 3.88% |
2001 Q4 | 3.22 Million USD | -0.18% |
2001 FY | - USD | 20.94% |
2001 Q1 | 2.95 Million USD | 158.04% |
2000 Q4 | 1.14 Million USD | -64.37% |
2000 FY | - USD | 26.34% |
2000 Q3 | 3.21 Million USD | -0.12% |
2000 Q2 | 3.21 Million USD | 15.15% |
2000 Q1 | 2.79 Million USD | 177.54% |
1999 Q4 | -2.4 Million USD | -187.8% |
1999 Q3 | 4.1 Million USD | 5.13% |
1999 FY | - USD | -40.58% |
1999 Q1 | 4.4 Million USD | 5.0% |
1999 Q2 | 3.99 Million USD | -7.14% |
1998 Q3 | 3.3 Million USD | -12.12% |
1998 Q2 | 3.7 Million USD | -5.71% |
1998 Q1 | 3.8 Million USD | 800.0% |
1998 FY | - USD | 38.0% |
1998 Q4 | 4.3 Million USD | 37.93% |
1997 Q1 | 3.1 Million USD | 18.18% |
1997 Q4 | 1.6 Million USD | -116.67% |
1997 Q3 | 3.3 Million USD | -36.17% |
1997 Q2 | 3.3 Million USD | 80.77% |
1997 FY | - USD | -12.28% |
1996 Q3 | 3.1 Million USD | -12.5% |
1996 Q1 | 3.4 Million USD | -8.57% |
1996 FY | - USD | -20.28% |
1996 Q4 | 2.6 Million USD | -21.43% |
1996 Q2 | 3.4 Million USD | 0.0% |
1995 FY | - USD | 13.49% |
1995 Q3 | 2.9 Million USD | -13.33% |
1995 Q2 | 3 Million USD | 0.0% |
1995 Q1 | 3.4 Million USD | 3.45% |
1995 Q4 | 2.8 Million USD | 34.62% |
1994 Q1 | 3.2 Million USD | -29.55% |
1994 Q3 | 3.7 Million USD | 16.13% |
1994 Q4 | 2.8 Million USD | -19.44% |
1994 FY | - USD | 12.5% |
1994 Q2 | 3.1 Million USD | 0.0% |
1993 FY | - USD | 43.59% |
1993 Q4 | 3.2 Million USD | 22.22% |
1993 Q2 | 3 Million USD | 16.67% |
1993 Q1 | 2.6 Million USD | 26.32% |
1993 Q3 | 3.6 Million USD | 28.57% |
1992 Q3 | 2.6 Million USD | 78.57% |
1992 Q1 | 2.1 Million USD | 145.45% |
1992 FY | - USD | 95.0% |
1992 Q2 | 2.4 Million USD | -30.0% |
1992 Q4 | 1.9 Million USD | -24.0% |
1991 Q4 | -7.1 Million USD | -246.67% |
1991 Q3 | 3.2 Million USD | 7.14% |
1991 FY | - USD | -52.38% |
1991 Q2 | 3.1 Million USD | 7.69% |
1991 Q1 | 2.8 Million USD | 4.0% |
1990 Q3 | 2.2 Million USD | -26.09% |
1990 Q2 | 2.3 Million USD | 9.52% |
1990 FY | - USD | 25.37% |
1990 Q1 | 2.2 Million USD | 106.07% |
1990 Q4 | 2.5 Million USD | 47.06% |
1989 FY | - USD | 103.03% |
1989 Q4 | -34.6 Million USD | -343.66% |
1989 Q2 | 13.6 Million USD | 4.62% |
1989 Q1 | 13 Million USD | 158.3% |
1989 Q3 | 14.2 Million USD | 4.41% |
Name | EBITDA | EBITDA Difference |
---|---|---|
Acadia Healthcare Company, Inc. | 189.11 Million USD | 60.229% |
Addus HomeCare Corporation | 106.55 Million USD | 29.417% |
AirSculpt Technologies, Inc. | 28.31 Million USD | -165.654% |
Amedisys, Inc. | 216.91 Million USD | 65.326% |
Astrana Health, Inc. | 123.68 Million USD | 39.192% |
Aveanna Healthcare Holdings Inc. | 44.34 Million USD | -69.595% |
IMAC Holdings, Inc. | -5.94 Million USD | 1364.748% |
biote Corp. | 9.23 Million USD | -714.512% |
Cryo-Cell International, Inc. | -10.41 Million USD | 821.992% |
Cross Country Healthcare, Inc. | 129.33 Million USD | 41.847% |
COMPASS Pathways plc | -123.8 Million USD | 160.752% |
DocGo Inc. | 32.72 Million USD | -129.829% |
The Ensign Group, Inc. | 353.23 Million USD | 78.708% |
InnovAge Holding Corp. | 1.15 Million USD | -6417.504% |
The Joint Corp. | 9.14 Million USD | -722.734% |
LifeStance Health Group, Inc. | -104.92 Million USD | 171.681% |
Mobile-health Network Solutions Class A Ordinary Shares | -15.55 Million USD | 583.533% |
ModivCare Inc. | -26.75 Million USD | 381.166% |
NewGenIvf Group Limited | 384.3 Thousand USD | -19470.914% |
Option Care Health, Inc. | 376.79 Million USD | 80.039% |
P3 Health Partners Inc. | -81.07 Million USD | 192.773% |
P3 Health Partners Inc. | -81.07 Million USD | 192.773% |
The Pennant Group, Inc. | 30.36 Million USD | -147.66% |
Surgery Partners, Inc. | 446.1 Million USD | 83.14% |
Syra Health Corp. Class A Common Stock | -2.83 Million USD | 2752.152% |
Talkspace, Inc. | -22.01 Million USD | 441.671% |
Talkspace, Inc. | -22.01 Million USD | 441.671% |
The Oncology Institute, Inc. | -70.45 Million USD | 206.753% |
The Oncology Institute, Inc. | -70.45 Million USD | 206.753% |